ID   WAe009-A-58
AC   CVCL_A7NC
SY   COL4A5 heterozygote; DZMHe010-A-58
DR   BioSamples; SAMEA8811933
DR   hPSCreg; WAe009-A-58
DR   Wikidata; Q107117432
RX   PubMed=34419749;
CC   From: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=34419749; DOI=10.1016/j.scr.2021.102481;
RA   Tian, Lei
RA   Wu, Fu-Jian
RA   Bai, Rui
RA   Ma, Shu-Hong
RA   Zheng, Hui-Juan
RA   Liu, Wei-Jing
RA   Wang, Yao-Xian
RT   "Generation of a COL4A5 heterozygous mutation human embryonic stem
RT   cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9
RT   system.";
RL   Stem Cell Res. 55:102481-102481(2021).
//